Ulcerative Colitis Clinical Trials in Chicago

Showing 761-780 of 806 trials

Evaluation of Low Source of Signal in SCOUT DS

NCT01339637

The overall objective of this study is to increase the number of dark skin tone individuals in the data set and evaluate if this increase in dark skin tone data has an impact on the accuracy of the SCOUT DS Diabetes Risk Score (DRS).

Metabolic SyndromeImpaired Glucose ToleranceGestational Diabetes

VeraLight, Inc.196 participantsStarted Apr 2011

Birmingham, Alabama, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +2 more locations

COMPLETEDPhase 12.2 miles

Open-Label Adalimumab for Ulcerative Colitis Patients

NCT00421642

This is an open-label study of 20 patients designed to demonstrate the safety, tolerability and preliminary evidence of benefit of adalimumab in the treatment of subjects with Ulcerative Colitis, both in patients who have never received anit-TNF agents and in those who have lost response or developed intolerance to previous infliximab therapy.

Ulcerative Colitis

Mayo Clinic20 participantsStarted Oct 2006

Scottsdale, Arizona, United States • Chicago, Illinois, United States • Rochester, Minnesota, United States

COMPLETEDPhase 32.2 miles

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

NCT00471146

The purpose of this study is to determine whether investigational study drug, AG-013736, and gemcitabine are effective in the first-line treatment of advanced pancreatic cancer.

Carcinoma, Pancreatic Ductal

Pfizer630 participantsStarted Jul 2007

Antioch, California, United States • Corona, California, United States • Glendora, California, United States +201 more locations

Evaluation of Low Source of Signal in SCOUT DS

Open-Label Adalimumab for Ulcerative Colitis Patients

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Ulcerative Colitis Trials in Other Cities

Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction

Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting

Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care Setting

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Tiotropium

A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)

FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Megadyne Ace Incision/Dissection Study

A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)

US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor

ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)

Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

Other Conditions in Chicago